David Hallett - 01 Jan 2026 Form 3 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role: CSO
Signature: /s/Jonathan Golightly, attorney-in-fact
Issuer symbol: RXRX
Transactions as of: 01 Jan 2026
Net transactions value: $0
Form type: 3
Filing time: 09 Jan 2026, 19:18:55 UTC
Next filing: 10 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hallett David	CSO	C/O RECURSION PHARMACEUTICALS, 41 S. RIO GRANDE STREET, SALT LAKE CITY	/s/Jonathan Golightly, attorney-in-fact	09 Jan 2026	0002006495

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RXRX	Class A Common Stock						287,928	01 Jan 2026	Direct
holding	RXRX	Class A Common Stock						277,759	01 Jan 2026	Direct	F1
holding	RXRX	Class A Common Stock						28,454	01 Jan 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RXRX	Stock Option (Right to Buy)							01 Jan 2026	Class A Common Stock	70,037	$7.25	Direct	F3
holding	RXRX	Stock Option (Right to Buy)							01 Jan 2026	Class A Common Stock	740,686	$6.09	Direct	F4
holding	RXRX	Stock Option (Right to Buy)							01 Jan 2026	Class A Common Stock	56,531	$0.0100	Direct	F5
holding	RXRX	Stock Option (Right to Buy)							01 Jan 2026	Class A Common Stock	75,375	$0.0100	Direct	F6
holding	RXRX	Stock Option (Right to Buy)							01 Jan 2026	Class A Common Stock	80,510	$0.0100	Direct	F7
holding	RXRX	Stock Option (Right to Buy)							01 Jan 2026	Class A Common Stock	80,510	$0.0100	Direct	F8
holding	RXRX	Stock Option (Right to Buy)							01 Jan 2026	Class A Common Stock	9,241	$0.0100	Direct	F9
holding	RXRX	Stock Option (Right to Buy)							01 Jan 2026	Class A Common Stock	150,888	$0.0100	Direct	F7
holding	RXRX	Stock Option (Right to Buy)							01 Jan 2026	Class A Common Stock	150,888	$0.0100	Direct	F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents RSUs with each RSU representing the right to receive one share of Class A common stock. The RSUs vest in equal quarterly installments beginning February 15, 2025 through November 15, 2028, subject to the Reporting Person continuing to be a service provider through the applicable vesting date.
F2	Represents RSUs with each RSU representing the right to receive one share of Class A common stock. The RSUs vest in equal quarterly installments beginning May 15, 2025 through February 15, 2029, subject to the Reporting Person continuing to be a service provider through the applicable vesting date.
F3	The option vests as to one forty-eighth (1/48th) of the original 70,037 shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F4	The option vests as to one forty-eighth (1/48th) of the original 740,686 shares subject to the option on January 2, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F5	The option was vested as to 35,333 shares upon the Issuer's assumption of the option at the time of the acquisition of Exscientia plc on November 20, 2024, and the remaining 21,198 shares vest in equal amounts quarterly, starting on December 15, 2024 through March 15, 2026, subject to Reporting Person continuing as a service provider though each vesting date.
F6	This option is vested and fully exercisable.
F7	This option will become vested and exercisable on the Date Exercisable subject to the Reporting Person continuing as a service provider through such date.
F8	The option was vested as to 30190 shares upon the Issuer's assumption of the option at the time of the acquisition of Exscientia plc on November 20, 2024, and the remaining 50,320 shares vest in equal amounts quarterly, starting on December 15, 2024 through March 15, 2027, subject to Reporting Person continuing as a service provider though each vesting date.
F9	This option is vested and fully exercisable
F10	The option was vested as to 18,862 shares upon the Issuer's assumption of the option at the time of the acquisition of Exscientia plc on November 20, 2024, and the remaining 132,026 shares vest in equal amounts quarterly, starting on December 15, 2024 through March 15, 2028, subject to Reporting Person continuing as a service provider though each vesting date.